LORAZEPAM axapharm cpr 1 mg bte 20 pce
7680699470013
CH-69947
N05BA06
01.04.1.
Reimbursement limitations:
120PISL
Prescription limitée au maximum à 120 points. Iniectabilia sine limitatione
1 / 3
google
Details
- Product number
- 6994701
- CPT
- -
- Packaging group
- 20
- Unit
- Tablette(n)
- Composition
- lorazepamum 1 mg, lactosum monohydricum 80 mg, cellulosum microcristallinum, talcum, carboxymethylamylum natricum A, pro compresso corresp. natrium 0.42 mg.
Articles (1)
Lorazepam axapharm 1 mg, Tabletten
Tabletten
20
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
80.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.42 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 11.65
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
axapharm ag
6340 Baar
Authorization information
- Swissmedic authorization number
- 69947
- Drug name
- Lorazepam axapharm, Tabletten
- Galenic form
- TAB
- ATC Code
- N05BA06
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 12/08/2024
- Authorization expiration date
- 31/12/9999
- IT number
- 01.04.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LORAZEPAM axapharm cpr 1 mg bte 20 pce
- Description (DE)
- LORAZEPAM axapharm Tabl 1 mg Ds 20 Stk
- Market launch
- 12/08/2024
- Narcotic (BTM)
- B